Carfilzomib in Combination With Daratumumab, Lenalidomide and Dexamethasone in Transplant-ineligible NDMM Patients
Clinical trial NCT04065789 · COMPLETED
Trial details
- NCT number
- NCT04065789
- Sponsor
- Tel-Aviv Sourasky Medical Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-02
- Primary completion
- 2021-08-27
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.